Guardant Health
GH
#1003
Rank
โ‚ฌ21.19 B
Marketcap
157,94ย โ‚ฌ
Share price
1.75%
Change (1 day)
194.38%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -โ‚ฌ0.4 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚ฌ1.18 Billion. In 2025 the company made an earning of -โ‚ฌ0.38 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.4 Billion5.52%
2025 -โ‚ฌ0.38 Billion-4.03%
2024 -โ‚ฌ0.39 Billion-9.12%
2023 -โ‚ฌ0.43 Billion-26.73%
2022 -โ‚ฌ0.59 Billion69.96%
2021 -โ‚ฌ0.35 Billion56.35%
2020 -โ‚ฌ0.22 Billion252.69%
2019 -โ‚ฌ61.94 Million-17.22%
2018 -โ‚ฌ74.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚ฌ7.96 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚ฌ0.23 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA